Advanced search
Publication Cover
Postgraduate Medicine Volume 126, 2014 - Issue 7
Submit an article Journal homepage
298
Views
11
CrossRef citations to date
0
Altmetric
Clinical Features

Drugs and Acute Porphyrias: Reasons for a Hazardous Relationship

Giulia Roveri Centre for Porphyrias and Diseases from Disturbances of Amino Acid Metabolism, Division of Internal Medicine II, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy
, MD,
Fabio Nascimbeni Centre for Porphyrias and Diseases from Disturbances of Amino Acid Metabolism, Division of Internal Medicine II, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy
, MD,
Emilio Rocchi Centre for Porphyrias and Diseases from Disturbances of Amino Acid Metabolism, Division of Internal Medicine II, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy
, MD &
Paolo Ventura Centre for Porphyrias and Diseases from Disturbances of Amino Acid Metabolism, Division of Internal Medicine II, Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, ItalyCorrespondence[email protected]
, MD
Pages 108-120 | Published online: 13 Mar 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Delia D’Avola & Gloria Gonzalez Aseguinolaza. (2016) Prospect and progress of gene therapy in acute intermittent porphyria. Expert Opinion on Orphan Drugs 4:7, pages 711-717.
Read now

Articles from other publishers (10)

Yi Ren, Jiajia Wang, Shuang Li, Jiajia Lei, Yunfeng Liu, Yan Wang, Fei Gao, Jianhong Wang, Jianhong Yin & Jing Yang. (2023) Molecular analysis of eight splicing variants in the hydroxymethylbilane synthase gene. Frontiers in Genetics 14.
Crossref
Elena García Verdú, Aiora Blanco Hernández, Lara Maceda García & Ana Belén Piteiro Bermejo. (2023) Lo que las lesiones cicatriciales en el dorso de las manos esconden. Diagnóstico y comentario. Piel 38:9, pages 598-599.
Crossref
Rochus Neeleman, Kyra Musters, Margreet Wagenmakers, Sophie Mijnhout, Edith Friesema, Eric Sijbrands & Janneke Langendonk. (2022) Mortality in Pedigrees with Acute Intermittent Porphyria. Life 12:12, pages 2059.
Crossref
Andrea Ricci, Elena Di Pierro, Matteo Marcacci & Paolo Ventura. (2021) Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias. Diagnostics 11:12, pages 2205.
Crossref
Brittany C. KunzSharon A. CenterJohn F. RandolphJanelle D. WalkerApril E. ChoiKarl E. Anderson. (2020) Congenital erythropoietic protoporphyria and protoporphyric hepatopathy in a dog. Journal of the American Veterinary Medical Association 257:11, pages 1148-1156.
Crossref
Enrique Esteve-Valverde, Alfonso Tapiz-Reula, Domingo Ruiz & Jaume Alijotas-Reig. (2019) Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria. Rheumatology International 40:5, pages 777-783.
Crossref
Helene J. Bustad, Karen Toska, Caroline Schmitt, Marta Vorland, Lars Skjærven, Juha P. Kallio, Sylvie Simonin, Philippe Letteron, Jarl Underhaug, Sverre Sandberg & Aurora Martinez. (2020) A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. Molecular Therapy 28:2, pages 677-689.
Crossref
Joana Rigor, Sara Almeida Pinto & Daniela Martins-Mendes. (2019) Porphyrias: A clinically based approach. European Journal of Internal Medicine 67, pages 24-29.
Crossref
Geok Huey New, Pei-Yang Hsu & Meng-Hsing Wu. (2016) Acute intermittent porphyria exacerbation following in vitro fertilization treatment. Taiwanese Journal of Obstetrics and Gynecology 55:2, pages 281-284.
Crossref
Amy Chan, Abigail Liebow, Makiko Yasuda, Lin Gan, Tim Racie, Martin Maier, Satya Kuchimanchi, Don Foster, Stuart Milstein, Klaus Charisse, Alfica Sehgal, Muthiah Manoharan, Rachel Meyers, Kevin Fitzgerald, Amy Simon, Robert J Desnick & William Querbes. (2015) Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification. Molecular Therapy - Nucleic Acids 4, pages e263.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.